Contact us

ODS (Oral Dissolving Strips) CDMO Companies
Oral Strip Manufacturing Services

Your Trusted Partners for ODS and Oral Dissolving Strip Development & Manufacturing

Showing 0 facilities
Suggested Results

These facilities match your main criteria but not every optional filter — including other countries in the same region.

AdhexPharma SAS
France

AdhexPharma SAS

AdhexPharma

CDMO for transdermal patches and oromucosal films.

CONTROLLED SUBSTANCES: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

MARKETS: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), MHRA (UK)

REGION: Europe

COMPLIANCE: FDA (cGMP), ISO, EMA (EU GMP)

BATCH SIZE: Large, Small, Medium

USE: Human, Veterinary

SERVICES: Development services, Manufacturing services, Analytical / QC services

THERAPEUTIC AREAS OF EXPERTISE (ATC): (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (N) Nervous system

OEB (Occupational Exposure Banding): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

CATEGORY / PRODUCT: FDF / DRUG PRODUCTS

Oral Dissolving Strips (ODS), also known as oral thin films or oral strips, have emerged as an innovative and patient-centric oral solid dosage form. These thin polymeric films rapidly disintegrate or dissolve in the oral cavity without the need for water, offering improved convenience, faster onset of action, and enhanced patient compliance. As a result, experienced ODS / oral strips CDMO companies play a key role in bringing these advanced dosage forms from development to commercial manufacturing.

Specialized oral strips CDMOs support pharmaceutical and biotech companies across formulation development, process optimization, GMP manufacturing, and regulatory submission for both local and systemic drug delivery applications.


How to Choose ODS / Oral Strips CDMO Companies

Selecting the right oral dissolving strips CDMO is critical to ensure product performance, dose uniformity, and regulatory compliance. Key factors to consider include:

  • Formulation expertise: Experience with film-forming polymers, plasticizers, surfactants, sweeteners, and taste-masking technologies.
  • Content uniformity control: Proven analytical and in-process controls for low-dose and high-potency APIs.
  • Manufacturing know-how: Expertise in solvent casting, drying kinetics, thickness control, and cutting accuracy.
  • Scale-up capabilities: Smooth transition from pilot to commercial-scale oral strip production.
  • GMP compliance: Facilities designed for precision manufacturing of thin-film dosage forms.
  • Regulatory experience: Prior interactions with FDA, EMA, and other global authorities for ODS products.
  • Packaging solutions: Moisture-protective unit-dose packaging such as sachets or stick packs.

Partnering with a CDMO specialized in oral strips significantly reduces technical risk and accelerates development timelines.


Key Services Offered by ODS / Oral Strips Contract Manufacturers

Leading oral strips CDMO companies typically offer integrated end-to-end services, including:

  • Preformulation and excipient compatibility studies
  • Oral strip formulation development
  • Solvent casting and controlled drying processes
  • Process optimization and scale-up
  • GMP clinical and commercial manufacturing
  • In-process controls and content uniformity testing
  • Stability studies under ICH guidelines
  • Primary and secondary packaging development
  • CMC documentation and regulatory support

These services ensure consistent product quality, reproducibility, and compliance throughout the product lifecycle.


Advantages of Partnering with ODS / Oral Strips CDMOs

Collaborating with specialized oral dissolving strips CDMO companies offers several strategic advantages:

  • Rapid onset of action: Due to fast disintegration in the oral cavity.
  • Improved patient compliance: Especially for pediatric, geriatric, and dysphagic populations.
  • Precise low-dose delivery: Suitable for potent APIs.
  • Reduced development timelines: Leveraging validated platforms and processes.
  • Regulatory confidence: Backed by prior approvals and GMP inspections.

ODS CDMOs act as strategic partners in developing innovative, non-invasive oral drug delivery solutions.


ODS / Oral Strips CDMO Companies


Related Information


Let MAI CDMO Network Help You Find the Right ODS / Oral Strips CDMO Partner

At MAI CDMO Network, we connect pharmaceutical and biotech companies with the most qualified ODS / oral strips CDMO companies worldwide. Whether you are developing a fast-dissolving strip for rapid systemic absorption or a patient-friendly local therapy, our network helps you identify GMP-compliant partners aligned with your technical, commercial, and regulatory goals.

Looking for an experienced oral strips manufacturing partner? Contact us today to find the right CDMO for your project.